Skip to content

H2020FP7HORIZON

Instituto Investigacion Sanitaria Fundacion Jimenez Diaz

Country
ESSpain
Defence projects
0
Projects, all programmes
20
As coordinator
2
EU contribution (CORDIS)
EUR 4,575,373
Active
2011 to 2025

Projects

20 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
SGLT2-HYPESGLT2 INHIBITION FOR CARDIOVASCULAR ENDPOINT REDUCTION IN HYPERTENSION (SGLT2-HYPE)HORIZON2025ParticipantEUR 131,788
KitNewCareDeveloping a framework/model to environmentally sustainable and climate neutral health and care systems using the Kidney care pathwayHORIZON2024ParticipantEUR 372,779
CURE HEARTandBRAINCURE HEARTandBRAIN postdoctoral COFUND programme by CNICHORIZON2024Associated partnerEUR 0
IDEA4RCIntelligent Ecosystem to improve the governance, the sharing and the re-use of health Data for Rare CancersHORIZON2022ParticipantEUR 332,026
RESILIENCERemote Ischemic Conditioning in Lymphoma Patients Receiving Anthracyclines.H20202021ParticipantEUR 619,877
RITA-MI 2Rituximab in patients with acute myocardial infarction: a phase 2 placebo-controlled randomised clinical trialH20202021ParticipantEUR 383,500
STRATEGY-CKDSystem omics to unravel the gut-kidney axis in Chronic Kidney Disease.H20202020ParticipantEUR 250,905
unCoVerUnravelling Data for Rapid Evidence-Based Response to COVID-19H20202020ParticipantEUR 125,845
PROFIDImplementation of personalised risk prediction and prevention of sudden cardiac death after myocardial infarctionH20202020ParticipantEUR 83,500
AMELIEAnchored Muscle cELls for IncontinencEH20202020ParticipantEUR 345,775
PRECISMEDLYMAggressive T cell Lymphomas, integrated clinical and genomic analysis for a precision medicine.H20202020CoordinatorEUR 160,932
MATRIXNovel mitochondria-targeted therapies for cancer treatment-induced cardiotoxicityH20202019ParticipantEUR 525,938
SELNETSarcoma as a model to improve diagnosis and clinical care of rare tumors through a European and Latin American multidisciplinary networkH20202019CoordinatorEUR 567,270
CaReSyAnCombatting the CardioRenal Syndrome: towards an integrative Analysis to reduce cardiovascular burden in chronic kidney diseaseH20202018PartnerEUR 0
UshTherClinical trial of gene therapy with dual AAV vectors for retinitis pigmentosa in patients with Usher syndrome type IBH20202018ParticipantEUR 136,645
NanoSmellNanoSmells: Artificial remote-controlled odorantsH20202015Third partyNot stated
PRIORITYProteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy In TYpe 2 diabetic patients with normoalbuminuriaFP72012ParticipantEUR 25,640
PRESBYOPIABio-inspired optical corrections of presbyopiaFP72012ParticipantEUR 67,319
E-PREDICEEarly Prevention of Diabetes Complications in people with Hyperglycaemia in EuropeFP72012ParticipantEUR 402,860
EUROGENTEST2Genetic testing in Europe - Network for the further development, harmonization, validation and standardization of servicesFP72011ParticipantEUR 42,774

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.